These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32260545)

  • 1. Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies.
    Li Q; Kang C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
    Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease.
    Quek JP; Liu S; Zhang Z; Li Y; Ng EY; Loh YR; Hung AW; Luo D; Kang C
    Antiviral Res; 2020 Mar; 175():104707. PubMed ID: 31953156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of foot-and-mouth disease virus 3C protease: a viable target for antiviral drugs?
    Curry S; Roqué-Rosell N; Sweeney TR; Zunszain PA; Leatherbarrow RJ
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):594-8. PubMed ID: 17511659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug design for flavivirus proteases: what are we missing?
    Poulsen A; Kang C; Keller TH
    Curr Pharm Des; 2014; 20(21):3422-7. PubMed ID: 24001226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.
    VanBlargan LA; Davis KA; Dowd KA; Akey DL; Smith JL; Pierson TC
    J Virol; 2015 Aug; 89(16):8632-42. PubMed ID: 26063422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
    Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
    Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flavivirus polymerase as a target for drug discovery.
    Malet H; Massé N; Selisko B; Romette JL; Alvarez K; Guillemot JC; Tolou H; Yap TL; Vasudevan S; Lescar J; Canard B
    Antiviral Res; 2008 Oct; 80(1):23-35. PubMed ID: 18611413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Druggable Sites on Zika Virus NS3 Helicase Using X-ray Crystallography-Based Fragment Screening.
    Munawar A; Beelen S; Munawar A; Lescrinier E; Strelkov SV
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents.
    Karypidou K; Ribone SR; Quevedo MA; Persoons L; Pannecouque C; Helsen C; Claessens F; Dehaen W
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3472-3476. PubMed ID: 30286952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology.
    Nitsche C; Zhang L; Weigel LF; Schilz J; Graf D; Bartenschlager R; Hilgenfeld R; Klein CD
    J Med Chem; 2017 Jan; 60(1):511-516. PubMed ID: 27966962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches.
    Katritch V; Byrd CM; Tseitin V; Dai D; Raush E; Totrov M; Abagyan R; Jordan R; Hruby DE
    J Comput Aided Mol Des; 2007; 21(10-11):549-58. PubMed ID: 17960327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.